DE2036471A1 - - Google Patents

Info

Publication number
DE2036471A1
DE2036471A1 DE19702036471 DE2036471A DE2036471A1 DE 2036471 A1 DE2036471 A1 DE 2036471A1 DE 19702036471 DE19702036471 DE 19702036471 DE 2036471 A DE2036471 A DE 2036471A DE 2036471 A1 DE2036471 A1 DE 2036471A1
Authority
DE
Germany
Prior art keywords
compounds
carbon atoms
hydrogen
formula
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702036471
Other languages
German (de)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DE2036471A1 publication Critical patent/DE2036471A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/27—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system containing six carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
DE19702036471 1969-07-29 1970-07-23 Pending DE2036471A1 (en, 2012)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38073/69A GB1269657A (en) 1969-07-29 1969-07-29 Prostaglandin analogues, their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
DE2036471A1 true DE2036471A1 (en, 2012) 1971-02-11

Family

ID=10400988

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702036471 Pending DE2036471A1 (en, 2012) 1969-07-29 1970-07-23

Country Status (10)

Country Link
JP (2) JPS5028950B1 (en, 2012)
BE (1) BE754114A (en, 2012)
CH (2) CH571486A5 (en, 2012)
DE (1) DE2036471A1 (en, 2012)
FR (1) FR2059574B1 (en, 2012)
GB (1) GB1269657A (en, 2012)
HU (2) HU162687B (en, 2012)
NL (1) NL7010617A (en, 2012)
SE (1) SE383513B (en, 2012)
ZA (1) ZA704099B (en, 2012)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2258668A1 (de) * 1971-12-03 1973-08-02 Syntex Corp Prostaglandin-derivate
US3920723A (en) * 1969-07-29 1975-11-18 Upjohn Co 4-oxaprostaglandin e-type compounds
US3920724A (en) * 1969-07-29 1975-11-18 Upjohn Co 4-oxa prostaglandin f ' -type compounds
US3922298A (en) * 1969-07-29 1975-11-25 Upjohn Co 3-Oxa prostaglandin B-type compounds
US3923863A (en) * 1969-07-29 1975-12-02 Upjohn Co 4-Oxa prostaglandin A-type compounds
US3923865A (en) * 1969-07-29 1975-12-02 Upjohn Co 4-Oxa prostaglandin F{62 -type compounds
US3923864A (en) * 1969-07-29 1975-12-02 Upjohn Co 3-Oxa prostaglandin A-type compounds
US3923861A (en) * 1969-07-29 1975-12-02 Upjohn Co 3-Oxa prostaglandin F{331 -type compounds
US3923862A (en) * 1969-07-29 1975-12-02 Upjohn Co 4-Oxa prostaglandin {62 -type compounds
US3931279A (en) * 1973-05-21 1976-01-06 The Upjohn Company 5-Oxa prostaglandin F2.sub.α analogs
US3936487A (en) * 1970-06-17 1976-02-03 The Upjohn Company 3-Oxa prostaglandin Fα-type compounds
US3944593A (en) * 1969-07-29 1976-03-16 The Upjohn Company 3-Oxa prostaglandin E-type compounds
US3980692A (en) * 1973-05-21 1976-09-14 The Upjohn Company 5-Oxa-17,18-dehydroprostaglandin-E1 -type analogs
US3981902A (en) * 1973-05-21 1976-09-21 The Upjohn Company 5-Oxa-17,18-dehydroprostaglandin-F1.sub.α -type analogs

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001296A (en) * 1973-05-21 1977-01-04 The Upjohn Company 5-Oxa prostaglandin E1 analogs
JPS5215047U (en, 2012) * 1975-07-22 1977-02-02
JPS5235356A (en) * 1975-09-13 1977-03-17 Toyo Seisakusho:Kk Manufacturing method of heat recovery device using heat pipe
US4181725A (en) * 1977-05-02 1980-01-01 The Regents Of The University Of Michigan Method for alleviating psoriasis
JPS5491311U (en, 2012) * 1977-12-10 1979-06-28
JPS60238552A (ja) * 1984-05-09 1985-11-27 日本軽金属株式会社 カ−テンウオ−ル
EP0299914B2 (de) 1987-07-17 2003-04-23 Schering Aktiengesellschaft 9-Halogen-(Z)-prostaglandinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US5891910A (en) * 1987-07-17 1999-04-06 Schering Aktiengesellschaft 9-halogen-(Z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents
JPS6443107U (en, 2012) * 1987-09-08 1989-03-15
JPH0380812U (en, 2012) * 1989-08-16 1991-08-19

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923864A (en) * 1969-07-29 1975-12-02 Upjohn Co 3-Oxa prostaglandin A-type compounds
US3944593A (en) * 1969-07-29 1976-03-16 The Upjohn Company 3-Oxa prostaglandin E-type compounds
US3920724A (en) * 1969-07-29 1975-11-18 Upjohn Co 4-oxa prostaglandin f ' -type compounds
US3922298A (en) * 1969-07-29 1975-11-25 Upjohn Co 3-Oxa prostaglandin B-type compounds
US3923863A (en) * 1969-07-29 1975-12-02 Upjohn Co 4-Oxa prostaglandin A-type compounds
US3923865A (en) * 1969-07-29 1975-12-02 Upjohn Co 4-Oxa prostaglandin F{62 -type compounds
US3923862A (en) * 1969-07-29 1975-12-02 Upjohn Co 4-Oxa prostaglandin {62 -type compounds
US3923861A (en) * 1969-07-29 1975-12-02 Upjohn Co 3-Oxa prostaglandin F{331 -type compounds
US3920723A (en) * 1969-07-29 1975-11-18 Upjohn Co 4-oxaprostaglandin e-type compounds
US3936487A (en) * 1970-06-17 1976-02-03 The Upjohn Company 3-Oxa prostaglandin Fα-type compounds
DE2258668A1 (de) * 1971-12-03 1973-08-02 Syntex Corp Prostaglandin-derivate
US3931279A (en) * 1973-05-21 1976-01-06 The Upjohn Company 5-Oxa prostaglandin F2.sub.α analogs
US3980692A (en) * 1973-05-21 1976-09-14 The Upjohn Company 5-Oxa-17,18-dehydroprostaglandin-E1 -type analogs
US3981902A (en) * 1973-05-21 1976-09-21 The Upjohn Company 5-Oxa-17,18-dehydroprostaglandin-F1.sub.α -type analogs

Also Published As

Publication number Publication date
JPS5028950B1 (en, 2012) 1975-09-19
FR2059574B1 (en, 2012) 1974-03-22
GB1269657A (en) 1972-04-06
CH571486A5 (en, 2012) 1976-01-15
FR2059574A1 (en, 2012) 1971-06-04
CH571487A5 (en, 2012) 1976-01-15
NL7010617A (en, 2012) 1971-02-02
BE754114A (fr) 1971-01-29
HU162688B (en, 2012) 1973-03-28
HU162687B (en, 2012) 1973-03-28
JPS503311B1 (en, 2012) 1975-02-03
SE383513B (sv) 1976-03-15
ZA704099B (en) 1971-03-31

Similar Documents

Publication Publication Date Title
DE2036471A1 (en, 2012)
DE2322673A1 (de) Neue verbindungen vom prostaglandintyp und verfahren zu ihrer herstellung
US3914282A (en) Prostaglandin E{HD 1{B , F{HD 1{B , and A{HD 1 {B analogs
DE2318785A1 (de) Prostansaeurederivate
DE2317019A1 (de) Neue 4,5-didehydro-prostaglandine
DE2011969A1 (de) Neue Prostaglandin-Derivate und Verfahren zu deren Herstellung
DE2355540A1 (de) Neue derivate von prostaglandinanaloga und verfahren zu deren herstellung
US3767695A (en) Prostaglandin e1, f1, and a1 analogs
DE2118686A1 (de) Prostaglandinverbindungen und Verfahren zu ihrer Herstellung
US3936487A (en) 3-Oxa prostaglandin Fα-type compounds
CH634831A5 (en) Process for the preparation of optically active or racemic prostaglandins.
US3944593A (en) 3-Oxa prostaglandin E-type compounds
DE2165184A1 (de) Neue Analoga bekannter Prostaglandine und Verfahren zu ihrer Herstellung
US3845115A (en) 15-lower alkoxy pgf compounds
DE2539116C2 (de) ω-Nor-cycloalkyl-13,14-dehydro-prostaglandine, Verfahren zu ihrer Herstellung sowie sie enthaltende pharmazeutische Mittel
DE2610718A1 (de) Neue 16-phenoxy-prostaglandin-verbindungen
DE2610503C2 (de) Optisch aktive 13,14-Dehydro-11- desoxy-prostaglandine, Verfahren zu ihrer Herstellung und sie enthaltendes pharmazeutisches Mittel
DE2719901A1 (de) Pge- und 11-deoxy-pge-verbindungen mit einer methylengruppe am c-9
CH623570A5 (en, 2012)
DE2606051A1 (de) 2,2-difluor-prostaglandin-e, -f tief alpha, -f tief beta, -a und -b-analoga und verfahren zu deren herstellung
DE2716075A1 (de) Neue zwischenprodukte und verfahren zur herstellung von thromboxan-analoga
DE2345695A1 (de) Verfahren zur herstellung neuer analoga bekannter prostaglandine
DE2704932A1 (de) Prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14 und verfahren zu ihrer herstellung
DE2320552A1 (de) 4,5-dihehydro-prostaglandine und verfahren zu ihrer herstellung
US3929861A (en) 16- AND 16,16-METHYL AND ETHYL SUBSTITUTED PGF{HD 1{B -type compounds